39 C
Delhi
Thursday, April 25, 2024

Dr Reddy Labs launches Lenalidomide Capsules in US

Date:

Share post:

Donate-GC-Razorpay

Mumbai: Dr. Reddy’s Labs on Thursday announced the launch of Lenalidomide Capsules in the US market, , a therapeutic equivalent generic version of REVLIMID (lenalidomide) Capsules approved by U. S. Food and Drug Administration (USFDA).

With this volume-limited launch, Dr. Reddy’s is eligible for first-to-market, 180 days of generic drug exclusivity for Lenalidomide Capsules in 2.5 mg and 20 mg strengths.

‘We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity,” says Marc Kikuchi, CEO, North America Generics, Dr. Reddy’s Laboratories.

“Bringing a more affordable generic version to market creates greater patient access for this important drug.’

Dr. Reddy’s Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg, and 25 mg strengths, each in a bottle-count size of 21.

Related articles

ECoR offers economy meals for passengers at nine stations in summer

Bhubaneswar: The East Coast Railway (ECoR) will provide economy meals at nine important stations across its jurisdiction in...

J&K: Woman drug smuggler booked under Narco Act, 2 held in Baramulla

Srinagar: Police booked a woman drug smuggler under the Narco Act while two other peddlers were arrested with...

11 IS militants executed in Iraq

Baghdad: The Iraqi authorities executed 11 convicts accused of being members of the Islamic State (IS) group, a...

Zimbabwean president reshuffles cabinet

Harare: Zimbabwean President Emmerson Mnangagwa on Wednesday reshuffled his cabinet, eight months after he appointed a new cabinet...